Halla Thorsteinsdottir

Contact Information
Office Phone Number: 
416-978-6873
Dalla Lana School of Public Health
155 College Street
Toronto
ON
M5T 3M7
Current DLSPH Academic & Administrative Appointments
Current Position: 
Adjunct Professor
Division/Discipline: 
SGS Status: 
Full Member
Appointment Status: 
Administrative Positions: 
Research Interests
  • Global Public Health
  • Life Sciences in Developing Countries
  • Health Innovation Systems
  • North-South and South-South Collaboration
  • Globalisation of Science, Technology and Innovation
  • Genomics and Public Goods
  • Gender and Life Science Development
  • Scientometric Research in Developing Countries
  • Qualitative Research
Primary Teaching Responsibilities
  • Genomics, Bioethics and Public Policy
Honours and Awards
  • New Investigator Salary Award from CIHR (Canadian Institutes of Health Research) 2007-2012.
  • Maud Menten New Investigator Prize from CIHR (Canadian Institutes of Health Research) Institute of Genetics, for best Operating Grant application in peer review committee – November 2005
  • The Chevening- British Council Scholarship - 1994-1997
  • The Soroptimist International Scholarship – 1995-1996
  • Icelandic Federation of University Women Award - 1994-1995
  • Aga Khan Foundation Scholarship -1986-1988
  • Carleton University Scholarship - 1985-1986

 

Current Research Projects
  • 2005-2011 - Canada"s Health Research and Innovation Partnerships with Developing Countries
  • 2006-2010 - South-to-South Collaboration in Health Biotechnology
  • 2005-2011 - Regenerative Medicine Innovation in Developing Countries

 

Representative Publications
  • Thorsteinsdóttir H., Ray M., Kapoor AK., Daar AS., “Health biotechnology innovation on a global stage” Nature Reviews Microbiology. 2011 Feb;9(2):137-43.
  • Thorsteinsdóttir H. (ed). Building Bridges: A Study on South-South Collaboration in Health Biotechnology. Book to be published by IDRC & Academic Foundation.
  • Thorsteinsdóttir H., Melon CC, Ray M, et al, South-South Entrepreneurial Collaboration in Health Biotech. Nature Biotechnology.28,Pages:407–416Year published:, (2010).
  • McMahon, D.S., Daar, A.S., Singer, P.A., Thorsteinsdóttir, H. (2010). Brazil’s regenerative medicine sector: Small but innovative. Regenerative Medicine. 5(6) 863-876.
  •  McMahon D. Thorsteinsdóttir H, Singer PA, Daar AS. Cultivating Regenerative Medicine Innovation in China. Regenerative Medicine 5, 1, 35-44 (2010).
  • Ray M., DaarAS, SingerPA, ThorsteinsdóttirH. Globetrotting Firms? Canada’s Health Biotechnology Collaboration with Developing Countries. Nature Biotechnology, 27, 9, 806-814 (2009).
  • Thorsteinsdóttir H, (2008). Stratégies de promotion de la génomique comme bien public mondial, 185-222. Le Santé et le Bien Commun B.M. Knopper et Y. Joly (eds). Droit, Biotechnologie et Société. Les Éditions Thémis.
  • Thorsteinsdóttir H. (2007) The Role of the Health System in Health Biotechnology in Developing Countries. Technology Analysis and Strategic Management, September, 2007.
  • Abdelgafar B. and Thorsteinsdóttir H. (2007) Promoting partnerships in biotechnology for development. In Bruce Doern (ed). Innovation, Science and Environment: Montreal: McGill-Queens University Press.
  • Thorsteinsdóttir H., Saénz TW, Quach U, Daar AS, Singer PA, (2004) Cuba - innovation through synergy. Nature Biotechnology, 2004. 22: p. DC19-DC24.
  • Thorsteinsdóttir H, Daar AS, Smith RD., and Singer P A. (2003) Genomics – A Global Public Good? The Lancet,Vol 361, March 15, 891-892.